Should We Use Living Donor Grafts for Patients With Hepatocellular Carcinoma? Ethical Considerations

被引：49
|
作者：
Pomfret, Elizabeth A. [1 ]
Lodge, J. Peter A. [2 ]
Villamil, Federico G. [3 ]
Siegler, Mark [4 ]
机构：
[1] Lahey Clin Med Ctr, Dept Transplantat & Hepatobiliary Dis, Burlington, MA 01805 USA
[2] St James Univ Hosp, Hepatobiliary & Transplant Unit, Leeds, W Yorkshire, England
[3] British Hosp, Liver Transplantat Unit, Buenos Aires, DF, Argentina
[4] Univ Chicago, Dept Med, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA
来源：
LIVER TRANSPLANTATION | 2011年 / 17卷
关键词：
LIVER-TRANSPLANTATION; EXPANDED CRITERIA; ADULT PATIENTS; EXPERIENCE; SURVIVAL; MORBIDITY; DONATION; IMPACT;
D O I：
10.1002/lt.22356
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：S128 / S132
页数：5
相关论文
共 50 条
  • [1] Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation? No, never
    Hiatt, JR
    Carmody, IC
    Busuttil, RW
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 573 - 577
  • [2] An 8 Year Experience with Living Donor Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: Should We Stick to Conventional Criteria?
    Bhangui, Prashant
    Kakodkar, Rahul
    Mohanka, Ravi
    Rastogi, Amit
    Goja, Sanjay
    Menon, P. Balachandran
    Saigal, Sanjiv
    Soin, Arvinder
    LIVER TRANSPLANTATION, 2012, 18 : S92 - S92
  • [3] Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
    Akamatsu, Nobuhisa
    Sugawara, Yasuhiko
    Kokudo, Norihiro
    LIVER CANCER, 2014, 3 (02) : 108 - 118
  • [4] Wait and Transplant for Stage 2 Hepatocellular Carcinoma With Deceased-Donor Liver Grafts: How Long Should We Wait?
    Pinto Kruel, Cleber Rosito
    Chedid, Aljamir D.
    Grezzana-Filho, Tomaz J. M.
    TRANSPLANTATION, 2014, 97 (02) : E6 - E6
  • [5] Living donor liver transplantation: Ethical considerations
    Whitington, PF
    JOURNAL OF HEPATOLOGY, 1996, 24 (05) : 625 - 627
  • [6] Living Donor Liver Transplantation: Ethical Considerations
    Miller, Charles M.
    Smith, Martin L.
    Uso, Teresa Diago
    MOUNT SINAI JOURNAL OF MEDICINE, 2012, 79 (02): : 214 - 222
  • [7] De novo hepatocellular carcinoma in living donor liver grafts: A Japanese multicenter experience
    Goto, Ryoichi
    Kosai-Fujimoto, Yukiko
    Yagi, Shintaro
    Kobayashi, Tsuyoshi
    Akamatsu, Nobuhisa
    Shimamura, Tsuyoshi
    Imura, Satoru
    Ogiso, Satoshi
    Mizuno, Shugo
    Takatsuki, Mitsuhisa
    Fukuhara, Takasuke
    Kanto, Tatsuya
    Eguchi, Susumu
    Yanaga, Katsuhiko
    Ogura, Yasuhiro
    Fukumoto, Takumi
    Shimada, Mitsuo
    Hasegawa, Kiyoshi
    Ohdan, Hideki
    Uemoto, Shinji
    Soejima, Yuji
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Taketomi, Akinobu
    Maehara, Yoshihiko
    HEPATOLOGY RESEARCH, 2020, 50 (12) : 1365 - 1374
  • [8] Indications for living donor liver transplantation in patients with hepatocellular carcinoma
    Sugawara, Yasuhiko
    Inomata, Yukihiro
    HEPATOBILIARY SURGERY AND NUTRITION, 2016, 5 (05) : 429 - 432
  • [9] LIVING DONOR LIVER TRANSPLANTATION FOR PATIENTS WITH RECURRENT HEPATOCELLULAR CARCINOMA
    Takada, Yasutsugu
    Ueda, Mikiko
    Egawa, Hiroto
    Uemoto, Shinji
    LIVER TRANSPLANTATION, 2008, 14 (07) : S121 - S122
  • [10] Should we screen for hepatocellular carcinoma?
    Trinchet, Jean-Claude
    Ganne-Carrie, Nathalie
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (6-7): : 880 - 886
12345